| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 9 | 2026 | 154 | 1.640 |
Why?
|
| Parathyroid Hormone | 11 | 2023 | 44 | 1.190 |
Why?
|
| Osteocytes | 3 | 2026 | 14 | 1.000 |
Why?
|
| Fibroblast Growth Factors | 13 | 2022 | 77 | 0.980 |
Why?
|
| Calcium | 11 | 2023 | 587 | 0.900 |
Why?
|
| Histone Deacetylases | 2 | 2025 | 67 | 0.840 |
Why?
|
| Bone and Bones | 12 | 2024 | 152 | 0.830 |
Why?
|
| Bone Diseases | 1 | 2024 | 25 | 0.820 |
Why?
|
| Glucuronidase | 8 | 2018 | 25 | 0.740 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 333 | 0.650 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 17 | 0.640 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 29 | 0.630 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2017 | 11 | 0.630 |
Why?
|
| Bone Resorption | 4 | 2026 | 46 | 0.610 |
Why?
|
| Phosphates | 12 | 2017 | 104 | 0.570 |
Why?
|
| Osteoclasts | 5 | 2026 | 53 | 0.570 |
Why?
|
| Signal Transduction | 8 | 2026 | 3168 | 0.540 |
Why?
|
| Genetic Vectors | 1 | 2024 | 929 | 0.520 |
Why?
|
| Claudins | 1 | 2017 | 5 | 0.520 |
Why?
|
| Tight Junctions | 1 | 2017 | 22 | 0.510 |
Why?
|
| Dependovirus | 1 | 2024 | 760 | 0.510 |
Why?
|
| Gene Expression Regulation | 10 | 2017 | 1635 | 0.490 |
Why?
|
| Genetic Therapy | 1 | 2024 | 852 | 0.490 |
Why?
|
| Mice | 27 | 2026 | 11185 | 0.490 |
Why?
|
| Animals | 38 | 2026 | 21489 | 0.480 |
Why?
|
| Extremities | 1 | 2017 | 63 | 0.480 |
Why?
|
| Duodenum | 2 | 2006 | 41 | 0.470 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2026 | 25 | 0.470 |
Why?
|
| Bone Development | 3 | 2026 | 33 | 0.430 |
Why?
|
| Kidney | 9 | 2023 | 460 | 0.370 |
Why?
|
| Mice, Knockout | 9 | 2026 | 2168 | 0.340 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 3 | 2023 | 5 | 0.340 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2025 | 53 | 0.320 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2025 | 66 | 0.310 |
Why?
|
| Osteoblasts | 8 | 2026 | 204 | 0.300 |
Why?
|
| Lipid Metabolism | 2 | 2007 | 226 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 3504 | 0.260 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 146 | 0.250 |
Why?
|
| STAT2 Transcription Factor | 1 | 2026 | 9 | 0.240 |
Why?
|
| Ossification, Heterotopic | 1 | 2026 | 14 | 0.240 |
Why?
|
| Calcification, Physiologic | 4 | 2015 | 20 | 0.240 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2006 | 2 | 0.240 |
Why?
|
| Immobilization | 1 | 2006 | 14 | 0.240 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2025 | 14 | 0.230 |
Why?
|
| Homeostasis | 6 | 2023 | 383 | 0.230 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 32 | 0.230 |
Why?
|
| Endopeptidases | 1 | 2026 | 67 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2026 | 116 | 0.230 |
Why?
|
| Vitamin D | 6 | 2023 | 139 | 0.230 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2026 | 61 | 0.230 |
Why?
|
| Vascular Calcification | 1 | 2025 | 27 | 0.220 |
Why?
|
| Mitochondria | 2 | 2026 | 416 | 0.220 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2026 | 100 | 0.220 |
Why?
|
| Cell Line | 4 | 2026 | 2031 | 0.220 |
Why?
|
| Gene Expression | 3 | 2007 | 855 | 0.220 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 799 | 0.220 |
Why?
|
| Osteopontin | 2 | 2014 | 21 | 0.190 |
Why?
|
| Cell Differentiation | 6 | 2026 | 1391 | 0.190 |
Why?
|
| Humans | 26 | 2026 | 65826 | 0.190 |
Why?
|
| Lead | 1 | 2022 | 46 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2026 | 369 | 0.180 |
Why?
|
| Phosphorylation | 2 | 2025 | 963 | 0.180 |
Why?
|
| Stress, Psychological | 1 | 2006 | 475 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 325 | 0.170 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 10 | 0.170 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 4 | 0.170 |
Why?
|
| Calcitriol | 5 | 2017 | 25 | 0.170 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 3 | 2016 | 4 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 689 | 0.170 |
Why?
|
| Parathyroid Glands | 2 | 2018 | 9 | 0.160 |
Why?
|
| Rats | 7 | 2012 | 2005 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 297 | 0.150 |
Why?
|
| Hyperphosphatemia | 3 | 2016 | 3 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2012 | 189 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 347 | 0.150 |
Why?
|
| Isomaltose | 2 | 2008 | 2 | 0.140 |
Why?
|
| Oleic Acid | 2 | 2008 | 20 | 0.140 |
Why?
|
| RANK Ligand | 3 | 2023 | 23 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1573 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 140 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 68 | 0.120 |
Why?
|
| Renal Elimination | 1 | 2016 | 3 | 0.120 |
Why?
|
| Kidney Tubules | 1 | 2016 | 23 | 0.120 |
Why?
|
| Aging | 2 | 2017 | 784 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2006 | 184 | 0.120 |
Why?
|
| Hypophosphatemia, Familial | 3 | 2011 | 4 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2025 | 2194 | 0.100 |
Why?
|
| Dental Implants | 1 | 2013 | 2 | 0.100 |
Why?
|
| Osseointegration | 1 | 2013 | 5 | 0.100 |
Why?
|
| Glycemic Index | 1 | 2013 | 23 | 0.100 |
Why?
|
| Glucose | 2 | 2007 | 478 | 0.100 |
Why?
|
| Leukocytes | 1 | 2013 | 110 | 0.090 |
Why?
|
| Titanium | 1 | 2013 | 59 | 0.090 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 28 | 0.090 |
Why?
|
| Diet | 2 | 2007 | 540 | 0.090 |
Why?
|
| Dietary Proteins | 2 | 2009 | 44 | 0.090 |
Why?
|
| Anabolic Agents | 1 | 2011 | 8 | 0.090 |
Why?
|
| Growth Plate | 1 | 2011 | 14 | 0.090 |
Why?
|
| Osteochondrodysplasias | 1 | 2011 | 12 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2017 | 326 | 0.090 |
Why?
|
| Calcinosis | 1 | 2012 | 84 | 0.080 |
Why?
|
| Aorta | 1 | 2012 | 108 | 0.080 |
Why?
|
| Obesity | 2 | 2009 | 1279 | 0.080 |
Why?
|
| Male | 12 | 2025 | 31398 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 2010 | 30 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2011 | 377 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 432 | 0.070 |
Why?
|
| Hypertriglyceridemia | 1 | 2009 | 9 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2009 | 21 | 0.070 |
Why?
|
| Quercetin | 1 | 2009 | 29 | 0.070 |
Why?
|
| Uterus | 1 | 2009 | 41 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2009 | 104 | 0.070 |
Why?
|
| Calcium Channel Agonists | 1 | 2009 | 11 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 542 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2009 | 25 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 899 | 0.070 |
Why?
|
| Bone Density | 3 | 2017 | 142 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2009 | 115 | 0.070 |
Why?
|
| Inflammation | 3 | 2023 | 1198 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2026 | 238 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 926 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1583 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2007 | 10 | 0.060 |
Why?
|
| Phosphorus, Dietary | 1 | 2007 | 1 | 0.060 |
Why?
|
| Cordyceps | 1 | 2007 | 1 | 0.060 |
Why?
|
| Diet Therapy | 1 | 2007 | 15 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 80 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 286 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 83 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2026 | 38 | 0.060 |
Why?
|
| Protein Stability | 1 | 2026 | 96 | 0.060 |
Why?
|
| Restraint, Physical | 1 | 2006 | 58 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 910 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2025 | 38 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2006 | 214 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 197 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 180 | 0.050 |
Why?
|
| Female | 9 | 2021 | 34414 | 0.050 |
Why?
|
| Symporters | 1 | 2004 | 16 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 252 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 25 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2005 | 322 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 484 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2025 | 351 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2013 | 502 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2026 | 441 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2011 | 1561 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2004 | 113 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 100 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 213 | 0.050 |
Why?
|
| Sp7 Transcription Factor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Maxilla | 1 | 2022 | 4 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 200 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2329 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 1332 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 163 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2013 | 115 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 157 | 0.040 |
Why?
|
| Osteomalacia | 2 | 2012 | 5 | 0.040 |
Why?
|
| Sucrose | 2 | 2009 | 30 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2012 | 200 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 2018 | 8 | 0.030 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.030 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 7 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 2018 | 12 | 0.030 |
Why?
|
| Rats, Zucker | 2 | 2008 | 7 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 541 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 2018 | 19 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 128 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2018 | 92 | 0.030 |
Why?
|
| COS Cells | 2 | 2010 | 180 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 69 | 0.030 |
Why?
|
| Opossums | 2 | 2009 | 3 | 0.030 |
Why?
|
| Phenotype | 2 | 2011 | 1236 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 302 | 0.030 |
Why?
|
| Body Weight | 2 | 2009 | 377 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1226 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2016 | 1 | 0.030 |
Why?
|
| Aging, Premature | 1 | 2016 | 2 | 0.030 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2015 | 3 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 859 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1980 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 22 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2013 | 77 | 0.030 |
Why?
|
| Uremia | 1 | 2013 | 9 | 0.020 |
Why?
|
| Calcineurin | 1 | 2013 | 50 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 211 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 301 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 174 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 94 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2011 | 32 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 405 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 41 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 61 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2010 | 27 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 312 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 3778 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 107 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 408 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 345 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 696 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 302 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 196 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 25 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 99 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 676 | 0.020 |
Why?
|
| Fasting | 1 | 2009 | 52 | 0.020 |
Why?
|
| Flavonoids | 1 | 2009 | 57 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 326 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1291 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2008 | 21 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 364 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 62 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 172 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 626 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 611 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2007 | 3 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 178 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 30 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 24 | 0.020 |
Why?
|
| Receptors, Calcitonin | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2007 | 8 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 46 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2007 | 20 | 0.020 |
Why?
|
| Food, Formulated | 1 | 2007 | 10 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 266 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2007 | 111 | 0.020 |
Why?
|
| Cathepsins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 147 | 0.020 |
Why?
|
| Pancreas | 1 | 2007 | 153 | 0.020 |
Why?
|
| Tibia | 1 | 2007 | 76 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 65 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 10 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 237 | 0.010 |
Why?
|
| Adipocytes | 1 | 2008 | 276 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 148 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 33 | 0.010 |
Why?
|
| Triglycerides | 1 | 2007 | 249 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 28 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2005 | 80 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2005 | 67 | 0.010 |
Why?
|
| Cholesterol | 1 | 2007 | 262 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1589 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 371 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 80 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 240 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 320 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 436 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 208 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2005 | 109 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 301 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 165 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 362 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 195 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type II | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 204 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 35 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 52 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 647 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1100 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 297 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 875 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1229 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1665 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1042 | 0.010 |
Why?
|
| Adult | 2 | 2006 | 17567 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 1267 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 15141 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 18491 | 0.000 |
Why?
|